BSE filing, NSE: SKYGOLD. Summary written from the filing by ALFA Finder's alert engine.
Sky Gold and Diamonds Ltd: key numbers
- Share price
- ₹922.00
- Market cap
- ₹14,279 Cr
- Revenue (annual)
- ₹6,295 Cr
- Net profit (annual)
- ₹275.3 Cr
- P/E (TTM)
- 51.9×Sector 47.4×
- Promoter holding
- 51.74%+0.00% QoQ
- FII holding
- 4.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sky Gold and Diamonds Ltd
All →Sky Gold and Diamonds Fund Raise of ₹1,800 Cr
Sky Gold and Diamonds approved raising up to ₹1,800 crore through public or private offerings, including a QIP of equity or eligible securities. The board approved it on 27 October 2026 and shareholders at the EGM on 18 November 2026.
- Value
- ₹1,800 Cr
Sky Gold and Diamonds Earnings Call Transcript: Key Takeaways
Sky Gold delivers explosive revenue growth driven by aggressive export expansion and high-margin product shifts. Management prioritizes capital efficiency via an asset-light gold procurement model and disciplined acquisition integration.
Sky Gold and Diamonds Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,390.7 Cr (+61%), EBITDA ₹189.8 Cr (7.9% margin), PAT ₹129.4 Cr (+93%). H1 revenue ₹4,403.5 Cr; H1 operating cash flow ₹136.7 Cr, positive.
Sky Gold and Diamonds Results Update
Sky Gold and Diamonds issued a press release on its Q2 and H1 FY27 results. H1 consolidated revenue rose to Rs 4,403.5 crore, with PAT up 111.9%.
Sky Gold and Diamonds Annual General Meeting
Sky Gold and Diamonds has convened an EGM on 18-Nov-2026 to consider a special resolution for raising funds through issuance of securities. No specific instrument or amount is disclosed in this notice.
Sky Gold and Diamonds Fund Raise of ₹1,800 Cr
Sky Gold and Diamonds' EGM on 18 November 2026 seeks approval to raise up to ₹1,800 crore via equity-linked securities. Remote e-voting closes 17 November 2026.
- Value
- ₹1,800 Cr
Other annual general meeting announcements
All →Strides Pharma Science Annual General Meeting
Strides Pharma Science issued a postal ballot notice seeking shareholder approval to appoint Biren Gabhawala as Independent Director. Voting closes December 19, 2026.
Affordable Robotic & Automation Annual General Meeting
Affordable Robotic seeks postal ballot approval for a Rs.200 Crore related-party limit, loan and guarantee authority, and borrowing powers. E-voting closes 19 December 2026.
Cera Sanitaryware Annual General Meeting
Cera Sanitaryware seeks postal ballot approval to re-appoint Vikram Somany as Chairman and MD, and Anandh Sundar as Independent Director. E-voting closes 18 December 2026.
OnEMI Technology Solutions Annual General Meeting
OnEMI Technology Solutions (Kissht) seeks shareholder approval via postal ballot to appoint Venkatadri Chandrasekaran as Non-Executive Independent Director for 3 years. E-voting closes 18 December 2026.
Senores Pharmaceuticals Annual General Meeting
Senores Pharmaceuticals announced that shareholders passed two special resolutions via postal ballot, re-appointing Swapnil Shah as MD and Chetan Shah as whole-time director. Voting closed on 17 November 2026 with resolutions passing at over 99% in favour.
United Polyfab Gujarat Annual General Meeting
United Polyfab Gujarat's EGM on 18 November 2026 considered three independent director appointments. Results are pending the scrutiniser's report.